about
Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responsesMonobenzone-induced depigmentation: from enzymatic blockade to autoimmunityNLRP10 is a NOD-like receptor essential to initiate adaptive immunity by dendritic cellsImmunoprevention of chemical carcinogenesis through early recognition of oncogene mutationsEffective melanoma immunotherapy in mice by the skin-depigmenting agent monobenzone and the adjuvants imiquimod and CpG.Interleukin-10 mediated autoregulation of murine B-1 B-cells and its role in Borrelia hermsii infection.The role of lipopeptidophosphoglycan in the immune response to Entamoeba histolytica.B cell TLRs and induction of immunoglobulin class-switch DNA recombination.Toll-like receptor 4 is involved in inflammatory and joint destructive pathways in collagen-induced arthritis in DBA1J mice.Toll-like receptor 9 signaling acts on multiple elements of the germinal center to enhance antibody responses.Gamma delta T cells recognize haptens and mount a hapten-specific response.Site-specific protein modifications through pyrroline-carboxy-lysine residuesAdsorption of Toll-Like Receptor 4 Agonist to Alum-Based Tetanus Toxoid Vaccine Dampens Pro-T Helper 2 Activities and Enhances Antibody Responses.Antibody-recruiting molecules: an emerging paradigm for engaging immune function in treating human disease.Vaccine adjuvants: putting innate immunity to work.Enhanced antibody responses to a detoxified lipopolysaccharide-group B meningococcal outer membrane protein vaccine are due to synergistic engagement of Toll-like receptorsCD301b+ dendritic cells suppress T follicular helper cells and antibody responses to protein antigens.Why is neuroimmunopharmacology crucial for the future of addiction research?Integration of B cell responses through Toll-like receptors and antigen receptors.Differentiation of germinal center B cells and follicular helper T cells as viewed by tracking Bcl6 expression dynamics.Immune System Regulation in the Induction of Broadly Neutralizing HIV-1 Antibodies.Inflammatory mediators in mastitis and lactation insufficiency.General Strategies in Inflammasome Biology.Langerhans cells promote early germinal center formation in response to Leishmania-derived cutaneous antigens.Allergic host defences.Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response.Immunogenicity of antibody drug conjugates: bioanalytical methods and monitoring strategy for a novel therapeutic modality.Inhibition of antibody production in vivo by pre-stimulation of Toll-like receptor 4 before antigen priming is caused by defective B-cell priming and not impairment in antigen presentation.Co-Stimulation of BCR and Toll-Like Receptor 7 Increases Somatic Hypermutation, Memory B Cell Formation, and Secondary Antibody Response to Protein Antigen.Ligation of CD11c during vaccination promotes germinal centre induction and robust humoral responses without adjuvant.
P2860
Q24624348-61FDF946-D69E-4F4F-8515-28F8425380B8Q28241227-46A5E47E-5740-463C-AC23-8206D31C0F2AQ28586719-224E241E-36B8-40B3-8CF4-613AFD0645B5Q28652580-A8C1A761-DADD-4BAA-9B5F-C870B7AB95C4Q33586122-EF34869C-6A49-4DAC-A4E2-C105002B52EBQ33631177-2B720216-D537-47E6-A7E6-032BEF499CEFQ33633292-D0E13416-4D79-4DEB-ABBA-FBC1A67CD303Q33893517-206E9483-C64F-4918-AFFC-8DFD1F90D0CDQ33999768-D653A025-1CFC-4241-B6D0-BCC340B8BEE2Q34025386-81B19201-6E89-4CDB-AB86-6E207A1A8259Q34241427-3F9CFFBB-5BC6-4178-BD95-653C6307307BQ35081671-519D7F55-026A-4804-872C-3C90485D04A2Q36035019-13A6C699-6C76-490C-A8DE-20CCCACDA48CQ36108119-F7F20015-2370-42E9-A7F1-82C1D9FAC148Q36168232-D5CDD8C9-41B8-482A-BE3E-AD7E5C5CD961Q37260306-4FF96C84-9493-467E-876F-3A7E8B81B0C9Q37276771-4AACAEE0-142B-42A6-BA41-3C76B7CC7FE9Q37381509-D4BE652D-B2FA-4577-9B84-3D61DB27D494Q37994060-255893CE-AA94-4413-B577-9E6E446E5917Q38002488-F39567E3-648D-45D7-B84F-32269A2BB45DQ38220506-464ADA0E-D9EB-4C21-BDC7-1E3C76A7CD9DQ38222905-4784A38C-34D1-4DDB-9285-4DB20E51D098Q38909256-860AC40A-9900-408C-9E7A-F1AEF80B40BDQ39152557-16F7E617-A3EE-449C-B246-A540E4ABFC6EQ41190858-D76111CC-4B07-432E-8DF9-7D86D7CF81BEQ42227086-1E5C157F-0E97-4C81-8A41-394815796FADQ43096291-844E6E43-5D42-4102-8F13-060AE878FC2CQ43710319-4DAEDF0A-DE9F-41B5-8E55-6FDC559C51FFQ47221189-D04E33F0-7FF3-46D3-8083-6FA3295908B1Q53324315-91A12DB5-E42F-48E9-8EA9-DDFFCE2E036F
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunostimulatory activity of haptenated proteins.
@en
Immunostimulatory activity of haptenated proteins.
@nl
type
label
Immunostimulatory activity of haptenated proteins.
@en
Immunostimulatory activity of haptenated proteins.
@nl
prefLabel
Immunostimulatory activity of haptenated proteins.
@en
Immunostimulatory activity of haptenated proteins.
@nl
P2860
P356
P1476
Immunostimulatory activity of haptenated proteins.
@en
P2093
Noah W Palm
Ruslan Medzhitov
P2860
P304
P356
10.1073/PNAS.0809403105
P407
P577
2009-03-02T00:00:00Z